Moreover, PBMCs from GBS produced more TNF−α and IL−1β after stimulation with TLR2 and TLR4 agonists (PGN and LPS), indicating that TLR2 and TLR4 expression on PBMCs is involved in the pathogenesis of GBS (121). This evidence concerns the gene TLR2 and Guillain-Barre syndrome.